Dying to Survive—The p53 Paradox

Andrea Lees*, Tamas Sessler, Simon McDade*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

56 Downloads (Pure)

Abstract

The p53 tumour suppressor is best known for its canonical role as “guardian of the genome”, activating cell cycle arrest and DNA repair in response to DNA damage which, if irreparable or sustained, triggers activation of cell death. However, despite an enormous amount of work identifying the breadth of the gene regulatory networks activated directly and indirectly in response to p53 activation, how p53 activation results in different cell fates in response to different stress signals in homeostasis and in response to p53 activating anti-cancer treatments remains relatively poorly understood. This is likely due to the complex interaction between cell death mechanisms in which p53 has been activated, their neighbouring stressed or unstressed cells and the local stromal and immune microenvironment in which they reside. In this review, we evaluate our understanding of the burgeoning number of cell death pathways affected by p53 activation and how these may paradoxically suppress cell death to ensure tissue integrity and organismal survival. We also discuss how these functions may be advantageous to tumours that maintain wild-type p53, the understanding of which may provide novel opportunity to enhance treatment efficacy.
Original languageEnglish
Article number3257
JournalCancers
Volume13
Issue number13
DOIs
Publication statusPublished - 29 Jun 2021

Keywords

  • p53
  • cell death
  • apoptosis
  • targeted therapy

Fingerprint

Dive into the research topics of 'Dying to Survive—The p53 Paradox'. Together they form a unique fingerprint.

Cite this